BUSINESS
Novartis
WORLD
Novartis to keep making malaria and leprosy drugs
BUSINESS
Novartis reports soaring Q2 profits from blockbuster drug sales
HEALTH & FAMILY
Breast cancer drug shown to reduce recurrence risk
BUSINESS
Novartis raises year forecast after sales boost
BUSINESS
Novartis loses in patent appeal over multiple sclerosis drug
BUSINESS
Roche buys back own shares held by rival Novartis
MALAYSIA
Employee can only get 24 months back pay if reinstated, rules court
BUSINESS
Novartis profit jumps 49% as clients restock post-lockdown
BUSINESS
Weak generic drugs drag down Novartis’ Q1 profits
WORLD
Novartis teams up with Roche to make Covid pneumonia drug
WORLD
EU approves Novartis’ potential top selling cholesterol drug Leqvio
BUSINESS
It’ll take more than vaccines to fight virus, says Novartis CEO
BUSINESS
Novartis agrees to US$642 mil settlement over kickbacks to doctors
BUSINESS
Swiss giant Novartis halts Covid-19 hydroxychloroquine study
WORLD
Novartis, US regulators agree to malaria drug trial against Covid-19
BUSINESS
Novartis settles US drug price-fixing charges for US$195 mil
BUSINESS
Novartis’ free treatment draws flak for ‘lottery’ selection process
BUSINESS
Novartis agrees to buy Medicines Co in US$6.8 bil deal
BUSINESS
Novartis raises profit estimate after quarterly beat
HEALTH & FAMILY
Novartis says baby’s death may be tied to gene therapy
BUSINESS
Novartis sees 2018 profit soar 64% after exiting GSK venture
BUSINESS
Novartis pushes deeper into nuclear medicine with US$2.1 billion deal
BUSINESS